Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Effects of Medium Molecular Weight Heparinyl Arginine on Scorpion Venom-induced Pulmonary Edema in Rats

SEIICHI TAKEDA, TAKAO TODA and KAZUKI NAKAMURA
In Vivo May 2018, 32 (3) 537-539;
SEIICHI TAKEDA
1Research and Development Center, Fuso Pharmaceutical Industries Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sei-takeda@fuso-pharm.co.jp
TAKAO TODA
1Research and Development Center, Fuso Pharmaceutical Industries Ltd., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUKI NAKAMURA
2Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The aim of this study was to examine the inhibitory action of medium molecular weight heparinyl amino acid derivatives (MHADs) on scorpion venom (SV)-induced acute pulmonary edema. Materials and Methods: SV was injected into the tail vein of rats after MHAD pre-treatment. An hour later, lungs were removed from each experimental animal, followed by measurement of the lung/body index (LBI) and Na+/K+ ratio of the pulmonary tissue as indices for acute pulmonary edema. Results: Medium molecular weight heparinyl arginine (MHR)-administered rats exhibited significantly lower LBI and Na+/K+ ratios compared to control rats. Although the mechanism of inhibitory action of MHR on pulmonary edema is unclear, MHR inhibited the vascular permeability increase by SV because both LBI and Na+/K+ ratio of the pulmonary tissue remained at almost normal values. Conclusion: MHR may prevent scorpion venom-induced acute pulmonary edema and thus makes a good candidate for clinical use.

  • Medium molecular weight heparinyl arginine (MHR)
  • scorpion venom
  • pulmonary edema

One well-known anticoagulant, heparin (HE), produces many pharmacological effects. However, there is a limit to its clinical use due to common serious side effects like bleeding and bruising. In recent years, low molecular weight HE (LMWH) has been developed. LMWH has a reduced bleeding tendency compared with HE, but has similar pharmacological effects. We have synthesized and studied a novel medium molecular weight HE (MHE) and its amino acid derivatives (MHADs), in which eleven kinds of amino acids were adducted to MHE to develop safe and effective heparin derivatives. We found that some MHADs had a function as indirect radical scavengers (1-3). In this paper, we examined the inhibitory action of MHADs on scorpion venom (SV)-induced acute pulmonary edema.

Materials and Methods

Animals. Specific pathogen-free male Wistar rats (6 weeks old) were purchased from Charles River Laboratories Japan, Inc. (Yokohama, Japan), and used for the experiment after a one-week acclimation. The rats were maintained at 23±2°C (room temperature) and 50±5% relative humidity under an artificial 12-hour light-dark cycle (7:00 on-19:00 off). Food and water were given ad libitum during the experimental period. All procedures followed the office regulations for the care and use of laboratory animals approved by the animal experimentation committee of Fuso Pharmaceutical Industries Ltd (approval number: PDS9405).

Materials. Medium molecular weight heparinyl histidine (MHH), medium molecular weight heparinyl methionine (MHM), medium molecular weight heparinyl arginine (MHR), and medium molecular weight heparinyl tyrosine (MHY) were synthesized from HE (Scientific Protein Laboratories, Waunakee, WI, USA) at the Research and Development Center of Fuso Pharmaceutical Industries LTD (Osaka, Japan), and the mean molecular weight of each was 8,500-10,000 (4). Amino acids were purchased from Wako (Osaka, Japan).

Measurement of lung/body index (LBI) and Na+/K+ ratio of the pulmonary tissue. The SV-induced pulmonary edema rats were prepared after modification of the method by Freire-Maia L and de Matos IM (5). SV (Tityus serrulatus venom) (Sigma-Aldrich Co., St. Louis, MO, USA) was injected into the tail vein of rats 30 minutes after MHAD (5,000 μg/kg) or saline pre-treatment. An hour later, rats were decapitated and lungs were removed after bloodletting, and the wet weight of lungs was measured. LBI was calculated by the method of Freire-Maia L and de Matos IM (5) from the wet weight of the lungs.

Embedded Image

The Na+/K+ ratio of the pulmonary tissue was determined by flame photometry using the flame photometer MF-303 (JASCO Corporation, Tokyo, Japan).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Changes in LBI and Na+/K+ ratio of the pulmonary tissue in rats after injection of scorpion venom.

Statistical analysis. Data are represented as the mean±standard error (S.E.), and significance was evaluated by ANOVA followed by the Spjotvoll and Stoline test (corrected Tukey's test), because the number of samples among the groups was different. The differences were assessed at a significance level of 0.05.

Results

Investigation of suitable doses of SV for establishment of acute pulmonary edema in rats. When SV (250 or 500 μg/kg) was injected into the tail vein of rats, piloerection, dyspnea, exophthalmos, lacrimation with blood, spasm, sialorrhea, and squatting were observed. Remarkable pulmonary edema was observed on autopsy. The LBI and Na+/K+ ratio of the pulmonary tissue in rats administered 250 or 500 μg/kg of SV increased significantly (Table I).

In the group administered 500 μg/kg of SV, death was seen before the end of observations. Accordingly, we decided to administer 250 μg/kg of SV to rats in subsequent experiments.

Inhibitory effects of MHADs on the SV-induced acute pulmonary edema. Rats administered with MHR and MHY (5,000 μg/kg) exhibited significantly lower LBI values compared with the control rats (p<0.01). Furthermore, the MHR administered group had a significantly lower Na+/K+ ratio in the pulmonary tissue compared with the controls (p<0.05). On the other hand, MHH and MHM did not demonstrate any inhibitory effects on SV-induced acute pulmonary edema (Table II).

Discussion

In the present study, we examined the inhibitory effects of four kinds of MHADs on acute pulmonary edema. It is reported that acute pulmonary edema may occur by an increase in permeability of the alveolar capillary barrier in the case of acute lung injury (6-8), or by increase in pulmonary microvascular hydrostatic pressure in the case of cardiogenic pulmonary edema (9). We used SV derived from Tityus Serrulatus to induce the acute pulmonary edema in rats in this study. In Brazil, medically remarkable scorpions belong to the genus Tityus and the most severe poisoning is caused by Tityus Serrulatus (10). Miyamoto JG et al. demonstrated that intravenously injected Tityus Serrulatus venom (200 μg/kg) induced Evans blue extravasation in 30 min in airways and hemorrhage in 60 min in the lungs. Furthermore, interleukin-1β and interleukin-6 were detected at 60 min in lung homogenates using male Wistar rats (11). Comellas AP et al. examined the effects of Tityus serrulatus venom on the ability of the lung to clear fluid and on alveolar epithelial Na, K-ATPase. As a result, lung edema clearance decreased by up to approximately 60% in male Sprague-Dawley rats injected intraperitoneally with the venom (2 mg/kg), and Na, K-ATPase α1- and β1-subunit protein abundance and activity decreased by 50% at the basolateral membranes of alveolar epithelial type II cells incubated with scorpion venom (10 μg/ml) for 60 min as compared with those of controls (12).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Effects of MHM, MHH, MHY, and MHR (5,000 μg/kg) on the LBI and Na+/K+ ratio of the pulmonary tissue in rats after injection of scorpion venom.

In this study, we selected the LBI and Na+/K+ ratio as the indices to evaluate the extent of acute lung edema in rats and their results support the validity of our experimental protocol. Freire-Maia L and de Matos IM indicated that HE prevented acute pulmonary edema induced by Tityus serrulatus scorpion venom in rats and their results suggested the inhibitory action of HE to be related to a decrease in the vascular permeability in the lung (5). However, it is known that HE causes bleeding as its representative adverse effect. On the other hand, MHR demonstrated a significant inhibitory action against acute pulmonary edema. Furthermore, the bleeding tendency with MHR was reduced to one-eighteenth of that of HE according to the activated partial thromboplastin time (APTT) (1).

In conclusion, MHR may prevent scorpion venom-induced acute pulmonary edema via the decrease in vascular permeability and alveolar epithelial Na, K-ATPase with a low risk of hemorrhage.

Footnotes

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors declare no conflict of interest associated with this manuscript.

  • Received February 6, 2018.
  • Revision received February 25, 2018.
  • Accepted February 26, 2018.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Takeda S,
    2. Toda T,
    3. Nakamura K
    : Middle molecular weight heparinyl amino acid derivatives (MHADs) function as indirect radical scavengers in vitro. Pharmacol Pharmacy 7: 117-123, 2016.
    OpenUrl
    1. Takeda S,
    2. Toda T,
    3. Nakamura K
    : Inhibitory effects of medium molecular weight heparinyl amino acid derivatives on ischemic paw edema in mice. In Vivo 30: 433-437, 2016.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Takeda S,
    2. Toda T,
    3. Nakamura K
    : Effects of medium molecular weight heparinyl phenylalnine on superoxide dismutase activity in mice. In Vivo 30: 841-844, 2016.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Araki H,
    2. Nishikawa H,
    3. Tanaka S,
    4. Nakamura K,
    5. Ohtani H,
    6. Nishimura S,
    7. Shimada C,
    8. Takeda S,
    9. Kawai K,
    10. Kitagawa C,
    11. Kuwahara M,
    12. Abe T
    : Japan Patent Kokai 1997-286803, 1997.
  4. ↵
    1. Freire-Maia L,
    2. de Matos IM
    : Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. Toxicon 9: 1207-1210, 1993.
    OpenUrl
  5. ↵
    1. Ashbaugh DG,
    2. Bigelow DB,
    3. Petty TL,
    4. Levine BE
    : Acute respiratory distress in adults. Lancet 2: 319-323, 1967.
    OpenUrlCrossRefPubMed
    1. Piantadosi CA,
    2. Schwartz DA
    : The acute respiratory distress syndrome. Ann Intern Med 141: 460-470, 2004.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Wyncoll DL,
    2. Evans TW
    : Acute respiratory distress syndrome. Lancet 354: 497-501, 1999.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Ware LB,
    2. Matthay MA
    : Clinical practice. Acute pulmonary edema. N Engl J Med 353: 2788-2796, 2005.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Bucaretchi F,
    2. Fernandes LC,
    3. Fernandes CB,
    4. Branco MM,
    5. Prado CC,
    6. Vieira RJ,
    7. De Capitani EM,
    8. Hyslop S
    : Clinical consequences of Tityus bahiensis and Tityus serrulatus scorpion stings in the region of Campinas, southeastern Brazil. Toxicon 89: 17-25, 2014.
    OpenUrlCrossRef
  9. ↵
    1. Miyamoto JG,
    2. Andrade FB,
    3. Ferraz CR,
    4. Candido DM,
    5. Knysak I,
    6. Venancio EJ,
    7. Verri WA Jr.,
    8. Landgraf MA,
    9. Landgraf RG,
    10. Kwasniewski FH
    : A comparative study of pathophysiological alterations in scorpionism induced by Tityus serrulatus and Tityus bahiensis venoms. Toxicon 141: 25-33, 2018.
    OpenUrl
  10. ↵
    1. Comellas AP,
    2. Pesce LM,
    3. Azzam Z,
    4. Saidias FJ,
    5. Sznajder JI
    : Scorpion venom decreases lung liquid clearance in rats. Am J Respir Crit Care Med 167: 1064-1067, 2003.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo
Vol. 32, Issue 3
May-June 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Medium Molecular Weight Heparinyl Arginine on Scorpion Venom-induced Pulmonary Edema in Rats
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effects of Medium Molecular Weight Heparinyl Arginine on Scorpion Venom-induced Pulmonary Edema in Rats
SEIICHI TAKEDA, TAKAO TODA, KAZUKI NAKAMURA
In Vivo May 2018, 32 (3) 537-539;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effects of Medium Molecular Weight Heparinyl Arginine on Scorpion Venom-induced Pulmonary Edema in Rats
SEIICHI TAKEDA, TAKAO TODA, KAZUKI NAKAMURA
In Vivo May 2018, 32 (3) 537-539;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Effects of Medium Molecular Weight Heparinyl Phenylalanine on Type I Hypersensitivity
  • Google Scholar

More in this TOC Section

  • Evaluation of the Relationship Between miRNA-22-3p and Gal-9 Levels in Glioblastoma
  • Metformin Inhibits the Estrogen-mediated Epithelial-Mesenchymal Transition of Ectopic Endometrial Stromal Cells in Endometriosis
  • MCC950 Ameliorates Acute Exogenous Lipoid Pneumonia Induced by Sewing Machine Oil in Rats via the NF-κB/NLRP3 Inflammasome Pathway
Show more Experimental Studies

Similar Articles

Keywords

  • Medium molecular weight heparinyl arginine (MHR)
  • scorpion venom
  • pulmonary edema
In Vivo

© 2023 In Vivo

Powered by HighWire